CZ20024078A3 - Imidazopyridinová a imidazopyrimidinová činidla - Google Patents

Imidazopyridinová a imidazopyrimidinová činidla Download PDF

Info

Publication number
CZ20024078A3
CZ20024078A3 CZ20024078A CZ20024078A CZ20024078A3 CZ 20024078 A3 CZ20024078 A3 CZ 20024078A3 CZ 20024078 A CZ20024078 A CZ 20024078A CZ 20024078 A CZ20024078 A CZ 20024078A CZ 20024078 A3 CZ20024078 A3 CZ 20024078A3
Authority
CZ
Czechia
Prior art keywords
compound
nmr
alkyl
mmol
cycloalkyl
Prior art date
Application number
CZ20024078A
Other languages
Czech (cs)
English (en)
Inventor
Kuo-Long Yu
Rita L. Civiello
Keith D. Combrink
Hatice Belgin Gulgeze
Ny Sin
Xiangdong Wang
Nicholas A. Meanwell
Brian Lee Venables
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of CZ20024078A3 publication Critical patent/CZ20024078A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CZ20024078A 2000-06-13 2001-05-08 Imidazopyridinová a imidazopyrimidinová činidla CZ20024078A3 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21144700P 2000-06-13 2000-06-13
US26336301P 2001-01-22 2001-01-22

Publications (1)

Publication Number Publication Date
CZ20024078A3 true CZ20024078A3 (cs) 2003-08-13

Family

ID=26906145

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20024078A CZ20024078A3 (cs) 2000-06-13 2001-05-08 Imidazopyridinová a imidazopyrimidinová činidla

Country Status (20)

Country Link
US (1) US6489338B2 (enExample)
EP (1) EP1311268A4 (enExample)
JP (1) JP2004503501A (enExample)
KR (1) KR20030008151A (enExample)
CN (1) CN1436079A (enExample)
AR (1) AR029128A1 (enExample)
AU (2) AU7290601A (enExample)
BR (1) BR0111569A (enExample)
CA (1) CA2412327A1 (enExample)
CZ (1) CZ20024078A3 (enExample)
HU (1) HUP0400766A2 (enExample)
IL (1) IL152889A0 (enExample)
MX (1) MXPA02012204A (enExample)
NO (1) NO20025977L (enExample)
NZ (1) NZ523566A (enExample)
PE (1) PE20011348A1 (enExample)
PL (1) PL360290A1 (enExample)
RU (1) RU2003100828A (enExample)
UY (1) UY26758A1 (enExample)
WO (1) WO2001095910A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774134B2 (en) * 2000-12-20 2004-08-10 Bristol-Myers Squibb Company Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
PL369432A1 (en) 2001-12-10 2005-04-18 Bristol-Myers Squibb Company Bis hydrochloride monohydrate salt of rsv fusion inhibitor
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
AU2003294249A1 (en) * 2002-11-08 2004-06-03 Trimeris, Inc. Hetero-substituted benzimidazole compounds and antiviral uses thereof
WO2005016275A2 (en) * 2003-08-05 2005-02-24 3M Innovative Properties Company Formulations containing an immune response modifier
JP4537407B2 (ja) 2003-10-30 2010-09-01 ベーリンガー インゲルハイム (カナダ) リミテッド Rsvポリメラーゼインヒビター
EP1697377B1 (en) 2003-12-24 2011-01-26 Biota Scientific Management Pty. Ltd. Polycyclic agents for the treatment of respiratory syncytial virus infections
GB0406282D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406279D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
WO2006033703A1 (en) * 2004-07-27 2006-03-30 Gilead Sciences, Inc. Imidazo[4,5-d]pyrimidines, their uses and methods of preparation
US7884215B2 (en) 2005-06-20 2011-02-08 Bonfanti Jean-Francois 2-substituted benzimidazoles
US8178694B2 (en) 2005-06-20 2012-05-15 Tibotec Pharmaceuticals Ltd. Heterocyclylaminoalkyl substituted benzimidazoles
EP1896473B1 (en) 2005-06-20 2011-10-19 Tibotec Pharmaceuticals 1-[[2-amino-3-(substituted alkyl)-3h-benzimidazolyl]methyl]-3-subtituted-1,3-dihydro-benzoimidazol-2-ones as inhibitors of respiratory syncytial virus replication
TWI423972B (zh) 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑
WO2009084544A1 (ja) * 2007-12-27 2009-07-09 Idemitsu Kosan Co., Ltd. 含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子
US20100278835A1 (en) 2009-03-10 2010-11-04 Astrazeneca Uk Limited Novel compounds 660
RU2407738C1 (ru) * 2009-07-03 2010-12-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Противовирусный активный компонент, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний
TWI508968B (zh) 2010-02-08 2015-11-21 Biota Scient Management 用於治療呼吸道融合性病毒感染的化合物
JPWO2011115150A1 (ja) * 2010-03-18 2013-07-04 興和株式会社 ベンゾチアジン化合物の製造方法
US8796303B2 (en) 2010-11-26 2014-08-05 Biota Scientific Management Pty Ltd. Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
TWI515187B (zh) 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
TWI530495B (zh) 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 苯并咪唑呼吸道融合病毒抑制劑
TWI527814B (zh) 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
TWI541241B (zh) * 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
TWI501967B (zh) 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
CN103893173B (zh) * 2011-03-23 2016-02-24 上海市第一人民医院 靶向人La蛋白的先导化合物及其在制备抗乙型肝炎病毒的药物中的用途
WO2013186229A1 (en) * 2012-06-11 2013-12-19 Ucb Pharma S.A. Tnf -alpha modulating benzimidazoles
AU2013276518A1 (en) * 2012-06-15 2014-12-04 Janssen Sciences Ireland Uc 4 - substituted 1, 3 - dihydro - 2H - benzimidazol - 2 - one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents
EA201590021A1 (ru) * 2012-06-15 2015-04-30 ЯНССЕН Ар ЭНД Ди АЙРЛЭНД Новые замещенные производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные гетероциклами, в качестве противовирусных средств против респираторного синцитиального вируса
KR20150033645A (ko) * 2012-06-15 2015-04-01 얀센 알 앤드 디 아일랜드 호흡기 합포체 바이러스의 항바이러스제로서의 벤즈이미다졸로 치환된 1,3-디하이드로-2h-벤즈이미다졸-2-온 유도체
KR102092612B1 (ko) * 2012-06-15 2020-03-25 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 호흡기 합포체 바이러스의 항바이러스제로서의 헤테로사이클로 치환된 1,3-디하이드로-2h-벤즈이미다졸-2-온 유도체
ME02835B (me) * 2012-10-16 2018-01-20 Janssen Sciences Ireland Uc Antivirusna rsv jedinjenja
JP2016145155A (ja) * 2013-04-30 2016-08-12 日本農薬株式会社 フタルアミド誘導体及び該誘導体を含有する農園芸用殺虫剤並びにその使用方法
RU2016120763A (ru) * 2013-10-29 2017-12-05 Медивир Аб Ингибиторы респираторного синцитиального вируса
WO2015065336A1 (en) * 2013-10-29 2015-05-07 Medivir Ab Respiratory syncytial virus inhibitors
US10358446B2 (en) 2015-10-14 2019-07-23 Zibo Biopolar Changsheng Pharmaceutical Co., Ltd. Bruton's tyrosine kinase inhibitors
WO2019046364A1 (en) * 2017-08-29 2019-03-07 Emory University INHIBITORS OF SYNCYTIAL RESPIRATORY VIRUS (RSV) REPLICATION AND USES THEREOF
EP4051663B1 (en) * 2019-10-30 2024-02-21 Janssen Sciences Ireland Unlimited Company Synthesis of 3-nitro-n-(2,2,2-trifluoroethyl)-4-pyridinamine
IL292526A (en) * 2019-10-30 2022-06-01 Janssen Sciences Ireland Unlimited Co Synthesis of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1h-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-3,1-dihydro- 2h-Imidazo[5,4-c]pyridin-2-one
JP2023528969A (ja) 2020-06-11 2023-07-06 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 3-({5-クロロ-1-[3-(メチルスルホニル)プロピル]-1H-インドール-2 イル}メチル)-1-(2,2,2-トリフルオロエチル)-1,3-ジヒドロ-2H-イミダゾ[4,5-c]ピリジン-2-オンのヘミ(L)-酒石酸塩形態及びそれを含む医薬組成物
WO2022184606A1 (en) * 2021-03-01 2022-09-09 Janssen Sciences Ireland Unlimited Company Synthesis of rilematovir
EP4469456A4 (en) * 2022-01-28 2025-12-31 Insilico Medicine Ip Ltd Ectunocleotide pyrophosphatase-phosphodiesterase 1 (ENPP1) inhibitors and their uses
WO2025026383A1 (en) * 2023-08-02 2025-02-06 Insilico Medicine Ip Limited Crytsalline forms of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324794A (en) 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds
NO155805C (no) 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
US5256668A (en) 1993-03-17 1993-10-26 American Home Products Corporation Aminopyrimidine derivatives as antiviral agents for respiratory syncytial virus
CA2197393A1 (en) 1996-02-13 1997-08-14 Yakov Gluzman (Deceased) Triazine containing anionic compounds useful as antiviral agents
AU759772B2 (en) 1998-01-29 2003-05-01 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
AU741946B2 (en) 1998-07-20 2001-12-13 Bristol-Myers Squibb Company Substituted benzimidazole antiviral agents
EP1400519B1 (en) 1999-06-28 2007-03-07 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors

Also Published As

Publication number Publication date
MXPA02012204A (es) 2003-10-15
CA2412327A1 (en) 2001-12-20
NZ523566A (en) 2004-08-27
WO2001095910A1 (en) 2001-12-20
US6489338B2 (en) 2002-12-03
BR0111569A (pt) 2003-04-29
KR20030008151A (ko) 2003-01-24
PE20011348A1 (es) 2002-02-07
PL360290A1 (en) 2004-09-06
HUP0400766A2 (hu) 2004-07-28
RU2003100828A (ru) 2004-06-27
US20020016309A1 (en) 2002-02-07
EP1311268A1 (en) 2003-05-21
AR029128A1 (es) 2003-06-04
IL152889A0 (en) 2003-06-24
JP2004503501A (ja) 2004-02-05
AU7290601A (en) 2001-12-24
CN1436079A (zh) 2003-08-13
AU2001272906B2 (en) 2004-08-26
EP1311268A4 (en) 2004-06-30
NO20025977L (no) 2003-01-29
UY26758A1 (es) 2002-01-31
NO20025977D0 (no) 2002-12-12

Similar Documents

Publication Publication Date Title
CZ20024078A3 (cs) Imidazopyridinová a imidazopyrimidinová činidla
JP7624025B2 (ja) アミノ酸化合物および使用方法
AU2019416589B2 (en) Heterocyclic compound intermediate, preparation method therefor and application thereof
AU2001272906A1 (en) Imidazopyridine and imidazopyrimidine antiviral agents
TWI541241B (zh) 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
JP5227304B2 (ja) 新規なヒドロキサム酸誘導体
EP3728207B1 (en) Quinazolinones as parp14 inhibitors
EP4520329A2 (en) Treatment of respiratory diseases with amino acid compounds
CN111406054B (zh) 作为组蛋白脱乙酰基酶6抑制剂的1,2,4-噁二唑衍生物
CA2509711A1 (en) Piperidine derivatives as ccr5 antagonists
KR20030036922A (ko) Hiv 인테그라제 억제제로서 유용한 아자- 및폴리아자-나프탈레닐 카복스아미드
EA022972B1 (ru) Бензимидазоловые ингибиторы респираторно-синцитиального вируса
KR20070026414A (ko) Hiv 인테그라제 억제제
AU2022255486A1 (en) Nek7 inhibitors
CA3251381A1 (en) BICYCLIC HETEROARYL COMPOUNDS AND THEIR USES
JP2025160175A (ja) Cd38阻害剤としてのキノリン及びアザキノリン
BR122024019819A2 (pt) Compostos de aminoácidos, seus usos e composição farmacêutica dos mesmos
ZA200210104B (en) Imidazopyridine and imidazopyrimidine antiviral agents.
HK1123303A1 (en) Heterocyclic janus kinase 3 inhibitors
HK1123303B (en) Heterocyclic janus kinase 3 inhibitors
HK1196355A (en) Compounds useful as inhibitors of choline kinase